Impact of socioeconomic status on biologics utilization in rheumatoid arthritis: revealing inequalities and healthcare efficiency
Hye Won Kim, Yeon Ju Lee, You-Jung Ha, Eun Bong Lee, Yun Jong Lee, Eun Ha Kang
Korean J Intern Med. 2024;39(4):668-679. Published online 2024 Feb 29 DOI: https://doi.org/10.3904/kjim.2023.276
Citations to this article as recorded by 
Compounding risks of chronic health conditions and substance use disorder on healthcare burden in the USA: Analysis of NSDUH data (2021–2023)
Ayodeji Iyanda, Richard Adeleke, Omowunmi Iyanda
Addictive Behaviors Reports.2025; 22: 100639. CrossRef
Development of explainable machine learning models to predict side effects in patients with rheumatoid arthritis taking methotrexate treatment: a nationwide multicentre cohort study
Junbeom Jang, Woo Jin Kim, Sang Won Park, Ki Won Moon
BMJ Open.2025; 15(11): e108527. CrossRef
Trends and health inequalities in the global, regional, and national prevalence of rheumatoid arthritis from 1990 to 2021: insights from the Global Burden of Disease Study 2021
Wenhui Li, Hualan Lin, Chunxia Huang, Jingjing Guo, Yingjie Leng, Yonglong Yan
Modern Rheumatology.2025;[Epub] CrossRef